Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Iwona Dankiewicz-Fares"'
Autor:
Katarzyna Napiórkowska-Baran, Joanna Zalewska, Sławomir Jeka, Iwona Dankiewicz-Fares, Marcin Ziętkiewicz, Ewa Szynkiewicz, Sylwia Kołtan, Adam Wawrzeńczyk, Ewa Więsik-Szewczyk, Zbigniew Bartuzi
Publikováno v:
Rheumatology, Vol 57, Iss 2, Pp 91-99 (2019)
Antibody determination is routinely used in everyday rheumatological practice. Its result repeatedly determines the diagnosis or exclusion of a particular disease. Antibodies are immunoglobulins, i.e. some of the most important proteins in the immune
Externí odkaz:
https://doaj.org/article/fc4ec5482a744ddabd30d25fe8580642
Publikováno v:
Rheumatology, Vol 61, Iss 5, Pp 389-394 (2023)
Rheumatic diseases are associated with a significant decline in quality of life, which is not only related to the progression of the underlying disease but also to the development of coexisting conditions. One of the possible complications in this gr
Externí odkaz:
https://doaj.org/article/aee026e31c0e468c94227da886342f7e
Autor:
Sylwia Kołtan, Marcin Ziętkiewicz, Ewa Więsik-Szewczyk, Sławomir Jeka, Zbigniew Bartuzi, Iwona Dankiewicz-Fares, Adam Wawrzeńczyk, Joanna Zalewska, Katarzyna Napiórkowska-Baran, Ewa Szynkiewicz
Publikováno v:
Rheumatology, Vol 57, Iss 2, Pp 91-99 (2019)
Reumatologia
Reumatologia
Antibody determination is routinely used in everyday rheumatological practice. Its result repeatedly determines the diagnosis or exclusion of a particular disease. Antibodies are immunoglobulins, i.e. some of the most important proteins in the immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83a064ef847e25d31d829194c5d5289b
https://www.termedia.pl/Determination-of-antibodies-in-everyday-rheumatological-practice,18,36512,1,1.html
https://www.termedia.pl/Determination-of-antibodies-in-everyday-rheumatological-practice,18,36512,1,1.html
Autor:
Iwona Dankiewicz-Fares, Brygida Kwiatkowska, Jerzy M Sobiecki, Sławomir Jeka, Włodzimierz Samborski, Bogdan Batko, Maria Majdan, Mariusz Korkosz
Background The GO-MORE study was an open-label, multinational, prospective study that investigated the efficacy and safety of adding golimumab to synthetic disease-modifying antirheumatic drugs (sDMARDs) in patients with active rheumatoid arthritis (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70fb19d6adde01c66e854a7ce04e1f88
https://ruj.uj.edu.pl/xmlui/handle/item/104629
https://ruj.uj.edu.pl/xmlui/handle/item/104629
Autor:
Tacjana, Barczyńska, Iwona, Dankiewicz-Fares, Halina, Bilińska-Reszkowska, Joanna, Zalewska, Sławomir, Jeka
Publikováno v:
Annales Academiae Medicae Stetinensis. 57(3)
Wegener's granulomatosis is a disease of unknown etiology associated with the presence of serum antibodies against proteinase 3 in most cases. It is characterized by formation of inflammatory infiltrates presenting as granulomas with fibrinoid necros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8741a1655e809492a781e74b2e483fc6
https://pubmed.ncbi.nlm.nih.gov/23383550
https://pubmed.ncbi.nlm.nih.gov/23383550